Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-002961
Filing Date
2021-06-11
Accepted
2021-06-11 18:56:52
Documents
1
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 form4-06112021_030630.html 4  
1 form4-06112021_030630.xml 4 7729
  Complete submission text file 0001415889-21-002961.txt   9122
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Issuer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address
RABINOWITZ DANIEL (Reporting) CIK: 0001857843 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37478 | Film No.: 211012762